This medication is taken by injection.
Zinbryta™ is a laboratory-created monoclonal antibody. It is designed to inhibit certain inflammatory functions of T cells and increase important immune cells that help regulate the immune system.
Zinbryta is approved by the U.S. Food and Drug Administration (FDA) to treat adult patients with relapsing forms of MS. It should be reserved for people who have had an inadequate response to two or more disease-modifying medications.
to read the Zinbryta Prescribing Information for healthcare professionals.
to read the Zinbryta Medication Guide for patients.
SupportZinbryta™ Patient Support Program
Financial Assistance Program